Immersion Corporation heads into the final session of April with an options market that has abruptly pivoted from defended to speculative — while short sellers quietly retreat from a position they built aggressively three weeks ago.
The most striking data point this week is in options. The put/call ratio collapsed to 0.249 on April 29 — its second-lowest reading of the past year, and more than four standard deviations below the 20-day average of 1.06. For context, IMMR's PCR has been running consistently above 1.0 since at least March, meaning puts have reliably outnumbered calls. Tuesday's reading represented a near-total reversal of that pattern in a single session. Whether that reflects fresh call buying, put liquidation ahead of the next event, or a structural shift in positioning, the directional signal is unambiguous: options traders turned decisively bullish on the day.
Short interest, meanwhile, has been compressing after a notable mid-month spike. Estimated short interest peaked around April 20 near 4.75 million shares — the highest level in at least six weeks — before falling sharply. By April 28 it had dropped to roughly 3.56 million shares, equivalent to about 10.7% of the free float. That's still a meaningful level for a small-cap name, but the week-on-week change of -25% signals that the crowding seen during the tariff-driven sell-off has partly unwound. Borrow costs remain benign at 0.67% — barely above the risk-free rate — and availability is not under visible strain, consistent with shorts covering rather than a lender-driven squeeze.
The ORTEX short score of 67.9 tells a similar story of receding but still-elevated pressure. It peaked at 78.7 on April 20 — the same day short interest hit its recent high — and has eased since. At the current level it still ranks in roughly the 67th percentile of the short-scoring universe, so the structural short thesis has not evaporated.
On the Street, the only active coverage comes from BWS Financial, which has maintained a Buy rating and a $13.50 target for several months — a price roughly double where the stock trades today at $5.87. Craig-Hallum trimmed its target to $11.00 from $14.00 in March 2025, while keeping its Buy. Both targets are stale relative to current trading levels, so the gap to the mean target of $13.50 should be treated as a rough structural observation rather than a current forecast. The stock's EPS surprise factor ranks in the 86th percentile and the dividend score hits 85, both of which support the bull case that IMMR generates real cash. The company declared a quarterly dividend of $0.08 in early April, continuing a policy that has stayed in place through the price drawdown.
The insider picture warrants attention. CEO Eric Singer sold shares three times in the past four months — roughly 30,000 shares in April alone at around $5.56, and a further 50,000 shares in early January at $6.41. These look like routine periodic sells, each representing less than 0.07% of the company, but the pattern is consistent: Singer has sold on a near-quarterly rhythm throughout 2025 and into 2026, with prices declining at each clip. Vanguard and BlackRock are the largest institutional holders with roughly 7% and 6.8% of shares respectively, and both added positions as of March 31 — Vanguard meaningfully so, adding 745,000 shares.
Immersion reported fiscal Q2 earnings on April 14, and the one-day reaction was a 9.5% gain — the strongest post-print move in the recent history. The five-day follow-through added another 5.7%. That contrasts with the prior three earnings events, all of which produced negative one-day reactions ranging from -2.3% to -10.6%. The next scheduled event is July 9.
The setup heading into May is therefore a stock that has pulled back 8.3% on the week to $5.87, with shorts partially covering, call buyers suddenly dominant in the options market, and a CEO who remains a steady seller into any bounce. The tension between those signals — speculative call demand versus consistent insider distribution — is the key dynamic to monitor in the weeks ahead.
See the live data behind this article on ORTEX.
Open IMMR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
